Nicotine flux: A potentially important tool for regulating electronic cigarettes

Nicotine and Tobacco Research

Volumn 17, Issue 2, 2015, Pages 165-167

  Eissenberg, Thomas ^a   Shihadeh, Alan ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTRONIC CIGARETTE; NICOTINE; NICOTINE FLUX; UNCLASSIFIED DRUG;

AVOIDANCE BEHAVIOR; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DEPENDENCE; EVIDENCE BASED PRACTICE; HEALTH EDUCATION; HEALTH HAZARD; HEALTH PROMOTION; HUMAN; LETTER; LONG TERM CARE; OUTCOME ASSESSMENT; PERSONAL EXPERIENCE; PLEASURE; POLICY; PRIORITY JOURNAL; PUBLIC HEALTH; REINFORCEMENT; SMOKING; TOBACCO; TOBACCO INDUSTRY; TOBACCO USE; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; ELECTRONIC CIGARETTE;

ELECTRONIC CIGARETTES; HUMANS; NICOTINE;

EID: 84922443617     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntu208     Document Type: Letter

References (18)

1. Farsalinos K, Voudris V, Le Houezec J. Risks of attempting to regulate nicotine flux in electronic cigarettes. Nicotine Tob Res. In press.
2. Shihadeh A, Eissenberg T. Electronic cigarette effectiveness and abuse liability: predicting and regulating "nicotine flux" [published online ahead of print September 1, 2014]. Nicotine Tob Res. doi:10.1093/ntr/ntu175
3. Glautier S. Measures and models of nicotine dependence: positive reinforcement. Addiction. 2004;99(suppl 1):30-50.
4. Eissenberg T. Measuring the emergence of tobacco dependence: the contribution of negative reinforcement models. Addiction. 2004;99(suppl 1):5-29.
5. Caponnetto P, Polosa R, Russo C, Leotta C, Campagna D. Successful smoking cessation with electronic cigarettes in smokers with a documented history of recurring relapses: a case series. J Med Case Rep. 2011;5: 585.
6. Spindle T, Breland A, Karaoghlanian N, Shihadeh AL, Eissenberg T. Preliminary results of an examination of electronic cigarette user puff topography: the effect of a mouthpiece-based topography measurement device on plasma nicotine and subjective effects [published online ahead of print September 19, 2014]. Nicotine Tob Res. doi:10.1093/ntr/ntu186
7. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15: 267-270.
8. Vansickel AR, Cobb CO, Weaver MF, Eissenberg TE. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19(8): 1945-1953.
9. Eissenberg T. Acute effects of electronic cigarettes in adults: nicotine delivery and puff topography. Paper presented at the 15th Annual Meeting of the Society for Research on Nicotine and Tobacco Europe, Santiago de Compostela, Spain, September 18; 2014.
10. Talih S, Balhas Z, Eissenberg T, et al. Effects of user puff topography, device voltage, and liquid nicotine concentration on electronic cigarette nicotine yield: measurements and model predictions [published online ahead of print September 3, 2014]. Nicotine Tob Res. doi:10.1093/ntr/ntu174
11. Balster RL, Bigelow GE. Guidelines and methodological reviews concerning drug abuse liability assessment. Drug Alcohol Depend. 2003;70:S13-S40.
12. Houtsmuller EJ, Fant RV, Eissenberg TE, Henningfield JE, Stitzer ML. Flavor improvement does not increase abuse liability of nicotine chewing gum. Pharmacol Biochem Behav. 2002;72: 559-568.
13. Houtsmuller EJ, Henningfield JE, Stitzer ML. Subjective effects of the nicotine lozenge: assessment of abuse liability. Psychopharmacology (Berl). 2003;167: 20-27.
14. Schuh KJ, Schuh LM, Henningfield JE, Stitzer ML. Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology (Berl). 1997;130: 352-361.
15. Carter LP, Stitzer ML, Henningfield JE, O'Connor RJ, Cummings KM, Hatsukami DK. Abuse liability assessment of tobacco products including potential reduced exposure products. Cancer Epidemiol Biomarkers Prev. 2009;18: 3241-3262.
16. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
17. Henningfield JE, Rose CA, Zeller M. Tobacco industry litigation position on addiction: continued dependence on past views. Tob Control. 2006;15(suppl 4):iv27-iv36.
18. Family Smoking Prevention and Tobacco Control Act (FSPTCA) of 2009, HR 1256, 111th Cong., 2010.